Who founded Mitochon Pharmaceuticals?

Mitochon Pharmaceuticals was founded by John G. Geisler in 2014.

Who are Mitochon Pharmaceuticals's investors?

Mitochon Pharmaceuticals's investors include Ben Franklin Technology Partners.

How much funding has Mitochon Pharmaceuticals raised?

Mitochon Pharmaceuticals has disclosed $825K raised across 2 rounds.

Where is Mitochon Pharmaceuticals headquartered?

Mitochon Pharmaceuticals is headquartered in Radnor, US.

Mitochon Pharmaceuticals

Radnor, US · Founded 2014 · Delaware corporation · 1 known investors

Mitochon is an early-stage biopharmaceutical company developing therapeutics. The page does not provide details about specific products, target indications, or customer segments beyond the biopharmaceutical sector.

Biotech Healthtech Longevity Medical Devices

Founders & leadership

Mitochon Pharmaceuticals was founded in 2014 by John G. Geisler.

John G. GeislerinFounder & Chief Scientific Officer

Peter CrooksExecutive

Robert AlonsoinFounder & CEO

Board

John IrwinBoard director

Investors · 1

Ben Franklin Technology Partners✓ verifiedHarrisburg · $50K – $250K

Reported raises · per SEC filings

Form D private placements

$825K disclosed across 2 rounds · 2014–2016

▶$425KraisedApr 2016 · 5 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

John IrwinDirector
Peter CrooksExecutive Officer
John GeislerExecutive Officer, Director
Robert AlonsoExecutive Officer, Director

Offering amount: $700K
Amount sold: $425K
Minimum investment: $25K
Proceeds to insiders: $6K
First sale: Apr 2016
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$400KraisedDec 2014 · 5 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

John IrwinDirector
Peter CrooksExecutive Officer
Robert AlonsoExecutive Officer, Director
John GeislerExecutive Officer, Director

Offering amount: $750K
Amount sold: $400K
Minimum investment: $25K
Proceeds to insiders: $6K
First sale: Nov 2014
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Mitochon Pharmaceuticals Announces $1 Million Award From ALS Association for Phase II Clinical Study - BioSpacebiospace.com · Aug 2026

Investors » Mitochon Pharmaceuticalsmitochonpharma.com · Nov 2021

Mitochon Pharma Awarded Grant From The Michael J. Fox Foundation To Support Mitochondrial Research In Parkinson’s - BioSpacebiospace.com · Oct 2017

Mitochon Raises $1.6M to Begin Clinical Tests of Mitochondrial Modulators for MS | Multiple Sclerosis News Todaymultiplesclerosisnewstoday.com · May 2016

Mitochon Pharma Raises $1.6 Million For Clinical Stage Development Of MP101 - BioSpacebiospace.com · May 2016

Frequently asked questions

What does Mitochon Pharmaceuticals do?: Mitochon is an early-stage biopharmaceutical company developing therapeutics. The page does not provide details about specific products, target indications, or customer segments beyond the biopharmaceutical sector.
Who founded Mitochon Pharmaceuticals?: Mitochon Pharmaceuticals was founded by John G. Geisler in 2014.
Who are Mitochon Pharmaceuticals's investors?: Mitochon Pharmaceuticals's investors include Ben Franklin Technology Partners.
How much funding has Mitochon Pharmaceuticals raised?: Mitochon Pharmaceuticals has disclosed $825K raised across 2 rounds.
Where is Mitochon Pharmaceuticals headquartered?: Mitochon Pharmaceuticals is headquartered in Radnor, US.